ACI
Neutral signalScored 2026-08-26 Drivers: Congress, fundamentals. Moteurs : Congrès, fondamentaux.
Research, not advice.
À propos
Albertsons Companies, Inc.
- Nom
- Albertsons Companies, Inc.
- Secteur
- Consumer Defensive
- Industrie
- Grocery Stores
- Bourse
- NYSE
- Capitalisation
- $6.8B
- Employés
- 275,000
- PDG
- Susan Morris
- Site web
- https://www.albertsonscompanies.com
- Marché
- BMBRFCRERFCUYTFCVPBFEMLAFGCHEF
Albertsons Companies, Inc., through its subsidiaries, operates in the food and drug retail industry in the United States. The company’s food and drug retail stores offer grocery products, general merchandise, health and beauty care products, pharmacy, vaccines, fuel, and other items and services. It also operates stores under various banners, including Albertsons, Safeway, Vons, Pavilions, Randalls, Tom Thumb, Carrs, Jewel-Osco, ACME, Shaw's, Star Market, United Supermarkets, Market Street, Haggen, Kings Food Markets, and Balducci's Food Lovers Market; and in-store pharmacies and branded coffee shops, fuel centers, distribution centers, and manufacturing facilities, as well as various digital platforms. Albertsons Companies, Inc. was founded in 1860 and is headquartered in Boise, Idaho.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
ACHAT TOTAL: 190777 titres (~2194558 USD)
- Insiders
- Moriarty Thomas MMORRIS SUSAN
- Total bought
-
$2,194,558
Avg buy (VWAP, 90d window) $11.49 vs last close —
- Total sold
-
—
Avg sell (VWAP, 90d window) —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- 2026-07-28
- Last synced
-
2026-10-20 00:36:23
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-07-31 | MCCOLLAM SHARON | Buy · P | 9,000 | $11.48 | $103,320 | Form 4 |
| 2026-07-28 | MORRIS SUSAN | Buy · P | 19,132 | $11.38 | $217,665 | Form 4 |
| 2026-07-27 | Moriarty Thomas M | Buy · P | 170,500 | $11.51 | $1,962,284 | Form 4 |
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-09-23 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2026-09-23 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2026-09-22 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2026-09-22 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2026-09-21 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2026-09-21 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2026-09-14 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2026-09-14 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2026-07-23 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2026-04-27 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-09-11 | Lisa C. McClain | Purchase | $1,001 - $15,000 |
| 2025-08-26 | Julia Letlow | Sale (Full) | $1,001 - $15,000 |
| 2025-07-22 | Lisa C. McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-07-16 | Lisa C. McClain | Purchase | $1,001 - $15,000 |
| 2025-01-24 | Julia Letlow | Purchase | $1,001 - $15,000 |
| 2024-07-03 | Jonathan Jackson | Sale (Full) | $15,001 - $50,000 |
| 2023-12-14 | Jonathan Jackson | Purchase | $15,001 - $50,000 |
| 2022-11-03 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-05-23 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2020-12-16 | Susie Lee | Sale (Full) | $1,001 - $15,000 |
| 2020-07-23 | Susie Lee | Purchase | $1,001 - $15,000 |
| 2020-06-26 | Susie Lee | Purchase | $1,001 - $15,000 |
Signal
Neutral signalScored 2026-08-26 Drivers: Congress, fundamentals. Moteurs : Congrès, fondamentaux.
ACI presents a deeply distressed financial profile with near-insolvent liquidity metrics, unsustainable leverage, and collapsing margins that fundamentally undermine any bullish thesis.
The first sentence of the analysis written for ACI on 2026-08-26 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Supports a bullish reading. Open-market purchases outweigh sales
- Congress Unavailable or mixed. 1 purchase disclosure year to date, a thin reading
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Unavailable or mixed. No stored price series
- Financial indicators Pulls against a bullish reading. Current ratio 0.86 · operating margin 0.9%
Market snapshot
Financial ratios
| Metric | Trend | 2026-02-28 | 2025-02-22 | 2024-02-24 | 2023-02-25 | 2022-02-26 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 27.2% | 27.7% | 27.8% | 28.0% | 28.8% | |
| Ebit Margin | 0.9% | 2.0% | 2.6% | 3.0% | 3.6% | |
| Ebitda Margin | 4.1% | 5.1% | 5.7% | 6.2% | 6.8% | |
| Operating Profit Margin | 0.9% | 1.9% | 2.6% | 3.0% | 3.4% | |
| Pretax Profit Margin | 0.3% | 1.4% | 2.0% | 2.5% | 2.9% | |
| Continuous Operations Profit Margin | 0.3% | 1.2% | 1.6% | 1.9% | 2.3% | |
| Net Profit Margin | 0.3% | 1.2% | 1.6% | 1.9% | 2.3% | |
| Bottom Line Profit Margin | 0.3% | 1.2% | 1.6% | 1.6% | 1.8% | |
| Current Ratio | 0.858 | 0.905 | 0.843 | 0.744 | 1.002 | |
| Quick Ratio | 0.197 | 0.217 | 0.180 | 0.177 | 0.463 | |
| Solvency Ratio | 0.115 | 0.133 | 0.144 | 0.146 | 0.141 | |
| Cash Ratio | 0.025 | 0.041 | 0.025 | 0.054 | 0.354 | |
| Price To Earnings Ratio | 44.750 | 12.455 | 9.529 | 8.969 | 10.886 | |
| Price To Earnings Growth Ratio | -0.591 | -0.467 | -5.455 | -0.557 | 0.180 | |
| Forward Price To Earnings Growth Ratio | -0.591 | -0.467 | -5.455 | -0.557 | 0.180 | |
| Price To Earnings Diluted Ratio | 44.750 | 12.530 | 9.614 | 9.048 | 11.007 | |
| Price To Earnings Diluted Growth Ratio | -0.592 | -0.474 | -5.456 | -0.568 | 0.132 | |
| Price To Book Ratio | 5.315 | 3.521 | 4.490 | 6.746 | 4.614 | |
| Price To Sales Ratio | 0.117 | 0.148 | 0.156 | 0.140 | 0.194 | |
| Price To Free Cash Flow Ratio | 18.508 | 15.907 | 19.638 | 15.522 | 7.319 | |
| Price To Operating Cash Flow Ratio | 4.123 | 4.447 | 4.639 | 3.807 | 3.972 | |
| Debt To Assets Ratio | 0.572 | 0.484 | 0.495 | 0.522 | 0.497 | |
| Debt To Equity Ratio | 8.331 | 4.189 | 5.183 | 9.317 | 5.060 | |
| Debt To Capital Ratio | 0.893 | 0.807 | 0.838 | 0.903 | 0.835 | |
| Long Term Debt To Capital Ratio | 0.821 | 0.686 | 0.729 | 0.822 | 0.723 | |
| Financial Leverage Ratio | 14.577 | 8.656 | 10.480 | 17.852 | 10.173 | |
| Working Capital Turnover Ratio | -92.398 | -86.340 | -47.610 | -72.553 | 827.714 | |
| Operating Cash Flow Ratio | 0.302 | 0.370 | 0.357 | 0.339 | 0.421 | |
| Operating Cash Flow Sales Ratio | 0.028 | 0.033 | 0.034 | 0.037 | 0.049 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.223 | 0.280 | 0.236 | 0.245 | 0.543 | |
| Debt Service Coverage Ratio | 1.894 | 3.203 | 2.909 | 2.041 | 2.258 | |
| Interest Coverage Ratio | 1.443 | 3.363 | 4.204 | 5.702 | 5.057 | |
| Short Term Operating Cash Flow Coverage Ratio | 1.863 | 3.513 | 2.762 | 1.640 | 2.391 | |
| Operating Cash Flow Coverage Ratio | 0.155 | 0.189 | 0.187 | 0.190 | 0.230 | |
| Capital Expenditure Coverage Ratio | 1.287 | 1.388 | 1.309 | 1.325 | 2.187 | |
| Dividend Paid And Capex Coverage Ratio | 1.095 | 1.204 | 1.152 | 0.447 | 1.822 | |
| Dividend Payout Ratio | 1.484 | 0.308 | 0.214 | 2.800 | 0.199 | |
| Enterprise Value Multiple | 7.283 | 6.312 | 5.831 | 5.295 | 5.384 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 27.2% | ▼-0.5% | ▼-0.7% |
| Ebit Margin | 0.9% | ▼-1.1% | ▼-1.5% |
| Ebitda Margin | 4.1% | ▼-1.0% | ▼-1.5% |
| Operating Profit Margin | 0.9% | ▼-1.1% | ▼-1.5% |
| Pretax Profit Margin | 0.3% | ▼-1.1% | ▼-1.5% |
| Continuous Operations Profit Margin | 0.3% | ▼-0.9% | ▼-1.2% |
| Net Profit Margin | 0.3% | ▼-0.9% | ▼-1.2% |
| Bottom Line Profit Margin | 0.3% | ▼-0.9% | ▼-1.0% |
| Current Ratio | 0.858 | ▼-0.046 | ▼-0.012 |
| Quick Ratio | 0.197 | ▼-0.019 | ▼-0.050 |
| Solvency Ratio | 0.115 | ▼-0.019 | ▼-0.021 |
| Cash Ratio | 0.025 | ▼-0.016 | ▼-0.074 |
| Price To Earnings Ratio | 44.750 | ▲32.295 | ▲27.432 |
| Price To Earnings Growth Ratio | -0.591 | ▼-0.124 | ▲0.787 |
| Forward Price To Earnings Growth Ratio | -0.591 | ▼-0.124 | ▲0.787 |
| Price To Earnings Diluted Ratio | 44.750 | ▲32.219 | ▲27.360 |
| Price To Earnings Diluted Growth Ratio | -0.592 | ▼-0.118 | ▲0.800 |
| Price To Book Ratio | 5.315 | ▲1.794 | ▲0.378 |
| Price To Sales Ratio | 0.117 | ▼-0.031 | ▼-0.034 |
| Price To Free Cash Flow Ratio | 18.508 | ▲2.600 | ▲3.129 |
| Price To Operating Cash Flow Ratio | 4.123 | ▼-0.324 | ▼-0.074 |
| Debt To Assets Ratio | 0.572 | ▲0.088 | ▲0.058 |
| Debt To Equity Ratio | 8.331 | ▲4.142 | ▲1.915 |
| Debt To Capital Ratio | 0.893 | ▲0.086 | ▲0.037 |
| Long Term Debt To Capital Ratio | 0.821 | ▲0.135 | ▲0.065 |
| Financial Leverage Ratio | 14.577 | ▲5.921 | ▲2.229 |
| Working Capital Turnover Ratio | -92.398 | ▼-6.059 | ▼-198.161 |
| Operating Cash Flow Ratio | 0.302 | ▼-0.067 | ▼-0.055 |
| Operating Cash Flow Sales Ratio | 0.029 | ▼-0.005 | ▼-0.008 |
| Free Cash Flow Operating Cash Flow Ratio | 0.223 | ▼-0.057 | ▼-0.083 |
| Debt Service Coverage Ratio | 1.895 | ▼-1.309 | ▼-0.567 |
| Interest Coverage Ratio | 1.443 | ▼-1.919 | ▼-2.511 |
| Short Term Operating Cash Flow Coverage Ratio | 1.863 | ▼-1.650 | ▼-0.571 |
| Operating Cash Flow Coverage Ratio | 0.155 | ▼-0.034 | ▼-0.035 |
| Capital Expenditure Coverage Ratio | 1.287 | ▼-0.101 | ▼-0.212 |
| Dividend Paid And Capex Coverage Ratio | 1.095 | ▼-0.109 | ▼-0.049 |
| Dividend Payout Ratio | 1.484 | ▲1.177 | ▲0.483 |
| Enterprise Value Multiple | 7.283 | ▲0.972 | ▲1.262 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $9.76B | $11.92B | $12.34B | $10.87B | $13.96B | |
| Enterprise value | $24.86B | $25.81B | $26.39B | $25.42B | $26.31B | |
| EV / Sales | 0.30x | 0.32x | 0.33x | 0.33x | 0.37x | |
| EV / Op. cash flow | 10.50x | 9.63x | 9.92x | 8.91x | 7.49x | |
| EV / Free cash flow | 47.14x | 34.44x | 42.01x | 36.31x | 13.80x | |
| EV / EBITDA | 7.28x | 6.31x | 5.83x | 5.29x | 5.38x | |
| Net debt / EBITDA | 4.42x | 3.40x | 3.10x | 3.03x | 2.53x | |
| Current ratio | 0.86x | 0.91x | 0.84x | 0.74x | 1.00x | |
| Income quality | 10.89x | 2.80x | 2.05x | 1.89x | 2.17x | |
| Graham number | $5 | $15 | $16 | $14 | $22 | |
| Graham net-net | -$39 | -$39 | -$40 | -$45 | -$47 | |
| Tax burden | 81.2% | 84.9% | 81.6% | 78.2% | 77.1% | |
| Interest burden | 34.7% | 71.1% | 76.4% | 82.7% | 81.3% | |
| Working capital | -$1.11B | -$692.0M | -$1.17B | -$2.16B | $17.9M | |
| Invested capital | $18.25B | $18.79B | $18.02B | $16.75B | $18.76B | |
| Return on assets | 0.8% | 3.3% | 4.5% | 5.3% | 5.3% | |
| Operating ROA | 2.6% | 5.3% | 7.2% | 7.8% | 8.1% | |
| Return on tangible assets | 0.9% | 3.7% | 5.2% | 6.0% | 5.9% | |
| Return on equity | 11.8% | 28.3% | 47.2% | 94.0% | 53.5% | |
| Return on invested capital | 2.9% | 5.7% | 7.6% | 8.2% | 7.9% | |
| Return on capital employed | 3.8% | 7.0% | 9.7% | 11.4% | 10.9% | |
| Earnings yield | 2.2% | 8.0% | 10.5% | 13.9% | 11.6% | |
| Free cash flow yield | 5.4% | 6.3% | 5.1% | 6.4% | 13.7% | |
| Capex / Op. cash flow | 77.7% | 72.0% | 76.4% | 75.5% | 45.7% | |
| Capex / Depreciation | 69.7% | 77.3% | 83.1% | 87.6% | 69.7% | |
| Capex / Sales | 2.2% | 2.4% | 2.6% | 2.8% | 2.2% | |
| SG&A / Sales | 26.3% | 25.6% | 25.2% | 25.2% | 25.5% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.1% | 0.1% | 0.1% | 0.2% | 0.1% | |
| Intangibles / Total assets | 12.5% | 12.0% | 12.6% | 12.8% | 11.3% | |
| Days sales outstanding | 4d | 4d | 3d | 3d | 3d | |
| Days payables outstanding | 24d | 26d | 27d | 27d | 30d | |
| Operating cycle | 35d | 35d | 35d | 34d | 35d | |
| Cash conversion cycle | 11d | 9d | 8d | 7d | 5d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Recent news
- 2026-10-16 Albertsons: 3 Key Takeaways for Long-Term Investors Albertsons paused financial guidance while conducting a multiyear business review. Same-store sales fell 0.8% during the second quarter of fiscal 2026.
- 2026-10-15 Albertsons® Companies, Inc. Appoints Harmit Singh to Board of Directors BOISE, Idaho--(BUSINESS WIRE)--Albertsons Companies, Inc. Appoints Harmit Singh to Board of Directors.
- 2026-10-15 Here Are Thursday’s Top Wall Street Analyst Research Calls: AngloGold Ashanti, Bank of America, Cirrus Logic, Crocs, Diamondback Energy, Devon Energy, Netflix, PayPal, Spotify Technolgy , and More Hotter-than-expected inflation sent stocks and crypto tumbling Wednesday, and Wall Street analysts wasted no time reshuffling their targets on Thursday, with major calls hitting Bank of America, Netflix, PayPal, and several energy giants all at once.
- 2026-10-14 Longleaf Partners Global Fund Q3 2026 Portfolio Review Biopharma company Regeneron reported a solid set of results, with key drug Dupixent continuing to outpace our and the market''s growth expectations. In the first part of the year before we invested, Abbott slightly missed earnings estimates while it was digesting its acquisition of Exact Sciences, along with a variety of turmoil in the medtech and infant nutrition industries. Digital and print publisher People Inc. was a detractor in the quarter, while hospitality and entertainment company MGM Resorts also detracted.
- 2026-10-14 Albertsons® Announces New Store in Valley Center, Bringing Fresh Food, Pharmacy Services and Jobs to Growing Community FULLERTON, Calif.--(BUSINESS WIRE)--Albertsons announced plans to build a new Albertsons grocery store in Valley Center, scheduled to open in spring 2028.
- 2026-10-14 These Analysts Revise Their Forecasts On Albertsons After Q2 Results Albertsons Companies, Inc. (NYSE:ACI) on Tuesday reported better-than-expected second-quarter fiscal 2026 results.
- 2026-10-14 Albertsons Is Betting on a Turnaround—But Will It Pay Off? Albertsons Companies TodayACIAlbertsons Companies$12.75 +0.21 (+1.65%) As of 10/13/2026 03:59 PM Eastern This is a fair market value price provided by Massive. Learn more.52-Week Range$10.86▼$20.00Dividend Yield5.33%P/E Ratio159.34Price Target$14.62Add to WatchlistAlbertsons Companies NYSE: ACI stock showed signs of bottoming in mid-October, rising by more than 2% following its Q2 fiscal year 2027 (FY2027) earnings report.
- 2026-10-14 Here Are Wednesday’s Top Wall Street Analyst Research Calls: Albemarle, Alcoa, Brinker International, Dell Technologies, Garmin, Hewlett Packard Enterprise, Lockheed Martin, NetApp, Trane Technologies, and More Wall Street analysts reshuffled their bets Wednesday, hitting several major tech and industrial names with surprise downgrades while selectively upgrading defense and commodity plays. Find out which stocks just got a fresh vote of confidence and which ones lost favor.
- 2026-10-14 Longleaf Partners Fund Q3 2026 Portfolio Review The market is regaining confidence in Avantor''s ability to grow organically and in Emmanuel Ligner''s turnaround plan. Biopharma company Regeneron reported a solid set of results, with key drug Dupixent continuing to outpace our and the market''s growth expectations. Building products company Fortune Brands Innovations saw its stock price decline in Q3, retracing Q2''s positive move related to excitement over Jesse Singh''s appointment as CEO.
- 2026-10-14 Albertsons Companies Q2 Earnings Call Highlights Albertsons Companies (NYSE: ACI) reported a 0.8% decline in second-quarter identical sales and outlined a broader turnaround effort centered on cost reductions, targeted price investments, operational simplification and a review of its portfolio of businesses and assets. Chief Executive Officer Susan Morris said the company saw "some early signs of improvement" during the quarter, including sequential